First human test for new drug delivery
NCT ID NCT03100903
Summary
This early-stage study aimed to understand how a new drug, BI 655130, is absorbed and processed by the body. It involved 36 healthy volunteers to compare how the drug behaves when given as an injection under the skin versus directly into a vein. The main goal was to check the drug's safety and how it moves through the body at this first stage of testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Life Science Services - Clinical Research
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.